Spots Global Cancer Trial Database for liposomal annamycin
Every month we try and update this database with for liposomal annamycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) | NCT03388749 | Leukemia, Myelo... | Liposomal Annam... | 18 Years - | Moleculin Biotech, Inc. | |
Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML | NCT00430443 | Acute Lymphocyt... Acute Myelogeno... | Liposomal Annam... | 12 Months - 21 Years | Callisto Pharmaceuticals | |
Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) | NCT03315039 | Leukemia, Myelo... | Liposomal Annam... | 18 Years - | Moleculin Biotech, Inc. | |
Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML | NCT00430443 | Acute Lymphocyt... Acute Myelogeno... | Liposomal Annam... | 12 Months - 21 Years | Callisto Pharmaceuticals | |
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) | NCT03315039 | Leukemia, Myelo... | Liposomal Annam... | 18 Years - | Moleculin Biotech, Inc. | |
Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) | NCT03388749 | Leukemia, Myelo... | Liposomal Annam... | 18 Years - | Moleculin Biotech, Inc. |